Inventor
Yu-Chuan Liang
Inventor
Baltimore, MD, US
Overview
Patents· 4 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes30%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
A23KFodder10%
A23LFoods, foodstuffs or non-alcoholic beverages, not otherwise provided for10%
A23VIndexing scheme relating to foods, foodstuffs or non-alcoholic beverages and lactic or propionic acid bacteria used in foodstuffs or food preparation10%
H01RElectrically-conductive connections10%
PatentTitleYear
10,931,044Board-to-board connector and board-to-board connector assembly202110,632,165Beneficial effect of 20209,877,978'Compositions comprising NDGA derivatives and sorafenib and their use in treatment of cancer'20187,728,036'Methods for delivery of catecholic butanes for treatment of tumors'2010Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2010–2018Patents assigned to UNIV JOHNS HOPKINS (2)· patent assignee history
2010Patents assigned to ERIMOS PHARMACEUTICALS LLC (1)· patent assignee history
2010–2018Based in Baltimore, MD, US· patent location history
2020Patents assigned to ACADEMIA SINICA (1)· patent assignee history
2020Patents assigned to UNIV NAT CHUNG HSING (1)· patent assignee history
2020Based in Taipei, TW· patent location history
2021Patents assigned to ADVANCED CONNECTEK INC (1)· patent assignee history
2021Based in New Taipei, TW· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UNIV JOHNS HOPKINS | 2 | 2010–2018 |
| ACADEMIA SINICA | 1 | 2020 |
| ADVANCED CONNECTEK INC | 1 | 2021 |
| ERIMOS PHARMACEUTICALS LLC | 1 | 2010 |
| UNIV NAT CHUNG HSING | 1 | 2020 |
Locations
| Location | Patents | Span |
|---|---|---|
| Baltimore, Maryland, US | 2 | 2010–2018 |
| New Taipei, TW | 1 | 2021 |
| Taipei, TW | 1 | 2020 |